We are live on ! Find out more
IMVTW

Immunovant, Inc. Warrants expiring 12/18/2024

Delisted

IMVTW was delisted on the 15th of June, 2020.

0 hedge funds and large institutions have $0 invested in Immunovant, Inc. Warrants expiring 12/18/2024 in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 170 (-17)

100% less capital invested

Capital invested by funds: $20M → $0 (-$20M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 17

Holders
Holders Change
-17
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
17
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
-$2.45M -1,020,000 Closed
GL
2
Governors Lane
New York
-$1.99M -828,004 Closed
EAM
3
Eventide Asset Management
Massachusetts
-$1.56M -651,900 Closed
CAC
4
Cowen and Company
New York
-$1.38M -574,286 Closed
DKCM
5
Davidson Kempner Capital Management
New York
-$1.07M -474,400 Closed
BFM
6
Boothbay Fund Management
New York
-$6.88M -442,201 Closed
SCM
7
Sio Capital Management
New York
-$715K -307,700 Closed
WAM
8
Wolverine Asset Management
Illinois
-$661K -275,622 Closed
ICM
9
Ionic Capital Management
New York
-$649K -270,566 Closed
6CM
10
683 Capital Management
New York
-$609K -253,600 Closed
GPCM
11
Granite Point Capital Management
Massachusetts
-$600K -250,000 Closed
WAM
12
Weiss Asset Management
Massachusetts
-$479K -199,600 Closed
PAMP
13
Polar Asset Management Partners
Ontario, Canada
-$392K -168,429 Closed
MP
14
Mangrove Partners
Connecticut
-$240K -100,000 Closed
RCM
15
Rivernorth Capital Management
Florida
-$240K -100,000 Closed
Walleye Trading
16
Walleye Trading
New York
-$69K -28,572 Closed
UBS Group
17
UBS Group
Switzerland
-$1K -245 Closed

IMVTW Hedge Fund Activity: Q2 2020 in Review

0 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Immunovant, Inc. Warrants expiring 12/18/2024 (IMVTW) for Q2 2020, worth a combined $0 — down 100% from $20M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of IMVTW and 0 opened new positions — a net loss of 17 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Boothbay Fund Management, exiting entirely with an estimated $6.88M sold.

  • 0 institutional investors held Immunovant, Inc. Warrants expiring 12/18/2024 (IMVTW) as of Q2 2020, down from 17 in Q1 2020.
  • Funds reported $0 of Immunovant, Inc. Warrants expiring 12/18/2024 stock for Q2 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Immunovant, Inc. Warrants expiring 12/18/2024 positions in Q2 2020 and 17 closed out, a net change of -17 holders.
  • The largest Immunovant, Inc. Warrants expiring 12/18/2024 seller in Q2 2020 was Boothbay Fund Management, an estimated $6.88M sold.

Based on aggregated 13F filings for Q2 2020.